Cefovecin sodium is a third-generation cephalosporin antibiotic used for the treatment of skin and soft tissue infections in cats and dogs. It is administered as an injectable formulation (subcutaneously or intravenously) due to its poor oral bioavailability. Its high protein binding rate results in prolonged antimicrobial activity, and it exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria, including Escherichia coli, Pasteurella multocida, Proteus spp., Klebsiella spp. (including Klebsiella pneumoniae), β-hemolytic streptococci, Staphylococcus aureus, and various anaerobes such as Fusobacterium, Bacteroides, Prevotella, Corynebacterium, and Clostridium spp.